Suppr超能文献

评估新的预测因子,以预测接受左侧乳腺癌辅助放疗患者的心脏和左前降支剂量。

Evaluation of a new predictor of heart and left anterior descending artery dose in patients treated with adjuvant radiotherapy to the left breast.

机构信息

Department of Radiation Oncology, Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Avenue, Toronto, ON, M4N 3M5, Canada.

Department of Radiation Oncology, London Regional Cancer Program, Western University, London, ON, Canada.

出版信息

Radiat Oncol. 2018 Jul 4;13(1):124. doi: 10.1186/s13014-018-1069-z.

Abstract

BACKGROUND

Heart-sparing techniques are time and resource intensive, although not all patients require the use of these strategies. This study evaluates the performance of different distance metrics in predicting the need for breath-hold radiotherapy in left-sided breast cancer patients receiving adjuvant radiotherapy.

METHODS

Fifty left-sided breast cancer patients treated with breast conserving surgery and adjuvant radiotherapy to the breast from a single institution were retrospectively studied. The left breast and organs at risk were contoured in accordance to guidelines and a plan with tangents was obtained using the free-breathing CT in supine position. Heart (mean heart dose (MHD), heart V25 Gy) and left anterior descending artery dosimetry were computed and compared against distance metrics under investigation (Contact Heart, 4th Arch and 5th Arch). Recursive partitioning analysis (RPA) was used to determine optimal cut-points for distance metrics for dosimetric end points. Receiver operating characteristic curves and Pearson correlation coefficients were used to evaluate the association between distance metrics and dosimetric endpoints. Univariable and multivariable logistic regression analysis was performed to identify significant predictors of dosimetric end points.

RESULTS

The mean MHD and heart V25 Gy were 2.3 Gy and 10.4 cm, respectively. With tangents, constraints for MHD (< 1.7 Gy and V25 Gy < 10 cm) were unattainable in 80% and 46% of patients, respectively. Optimal RPA thresholds included: Contact Heart (73 mm), 4th Arch (7 mm) and 5th Arch (41 mm). Of these, the 4th Arch had the highest overall accuracy, sensitivity, concordance index and correlation coefficient. All metrics were statistically significant predictors for MHD ≥ 1.7 Gy based on univariable logistic regression. Fifth Arch did not reach significance for heart V25 Gy ≥ 10 cm. Fourth Arch was the only predictor to remain statistically significant after multivariable analysis.

CONCLUSIONS

We propose a novel "4th Arch" metric as an accurate and practical tool to determine the need for breath-hold radiotherapy for left-sided breast cancer patients undergoing adjuvant radiotherapy with standard tangents. Further validation in an external cohort is necessary.

摘要

背景

心脏保护技术既耗时又耗资源,尽管并非所有患者都需要使用这些策略。本研究评估了不同距离指标在预测接受辅助放疗的左侧乳腺癌患者需要屏气放疗中的表现。

方法

回顾性研究了来自单一机构的 50 例接受保乳手术和辅助放疗的左侧乳腺癌患者。按照指南对左侧乳房和危及器官进行轮廓描绘,并在仰卧位自由呼吸 CT 上获得切线计划。计算心脏(平均心脏剂量(MHD),心脏 V25Gy)和左前降支剂量,并与研究中的距离指标(接触心脏、4 号弓和 5 号弓)进行比较。递归分区分析(RPA)用于确定距离指标的最佳截断点,以确定剂量学终点。使用受试者工作特征曲线和 Pearson 相关系数评估距离指标与剂量学终点之间的关联。进行单变量和多变量逻辑回归分析,以确定剂量学终点的显著预测因子。

结果

平均 MHD 和心脏 V25Gy 分别为 2.3Gy 和 10.4cm。使用切线,MHD(<1.7Gy 和 V25Gy<10cm)的约束在 80%和 46%的患者中无法达到。最佳 RPA 阈值包括:接触心脏(73mm)、4 号弓(7mm)和 5 号弓(41mm)。其中,4 号弓的总体准确性、灵敏度、一致性指数和相关系数最高。所有指标在单变量逻辑回归分析中均为 MHD≥1.7Gy 的统计学显著预测因子。第五弓对于心脏 V25Gy≥10cm 未达到统计学意义。多变量分析后,只有 4 号弓仍然是统计学上的显著预测因子。

结论

我们提出了一种新的“4 号弓”指标,作为一种准确实用的工具,用于确定接受标准切线辅助放疗的左侧乳腺癌患者是否需要屏气放疗。需要在外部队列中进一步验证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dce2/6032565/46b6dd0bd22c/13014_2018_1069_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验